US-Mexico IVF PGS Testing: How to Conquer Embryo Quality Challenges

2026-01-27 18:35:11，浏览量： 5次

 

In today's society, infertility has become a hidden pain for many couples. With delayed childbearing age and increased work pressure, more and more advanced-age pregnancy preparers face repeated failures due to poor embryo quality, making family dreams seem out of reach. Many women turn to overseas assisted reproduction for breakthroughs after unsuccessful natural pregnancies. US-Mexico IVF or egg freezing services help countless patients overcome these obstacles with their advanced laboratories and efficient plans. Through preimplantation genetic screening (PGS) technology, you can more precisely address embryo defects, avoid blind transplantation, and inject scientific protection into IVF-PGT cycles, enhancing overall success rates and newborn health levels.

 

PGS, as a key diagnostic tool for IVF, assesses chromosomal status in early embryo development, particularly suitable for solving genetic abnormalities and quality issues. In the cycle, women promote multi-follicle development in the ovaries through about two weeks of pituitary suppression drugs and subsequent hormone stimulation; during this period, regular blood tests and B-ultrasound monitor reactions to ensure safe egg retrieval. After egg retrieval, sperm-egg in vitro fertilization is cultured to the day 5 blastocyst stage, where a biopsy removes 5-10 cells for laboratory analysis. Abnormal embryos are excluded, and only normal ones are transplanted, greatly reducing miscarriage risks, suitable for advanced-age couples or those with genetic family history.

 

The IVF process emphasizes fine management, with every step from ovulation induction to transplantation affecting quality. PGS is applied at the blastocyst stage, utilizing the embryo's strong self-repair ability to avoid early damage; results are usually available within 4 weeks, supporting frozen embryo transfer and flexible cycle arrangement. Existing research shows that PGS can increase pregnancy rates per transplantation by over 20%, especially reducing miscarriage rates for women over 35. Through selective transplantation, IVF technology not only improves live birth rates but also prevents genetic disease transmission, providing a more reliable path for pregnancy preparation families.

 

The applicable population includes women aged 35 and above, who have high risks of egg chromosomal abnormalities; those with multiple miscarriages, possibly stemming from hidden genetic issues; and chromosomal translocation carriers, where PGS can precisely eliminate. Dr. Nathan Zhang points out that US-Mexico IVF commonly adopts IVF-PGT, screening embryo quality before transplantation, with success rates higher than unscreened ones. This technology is not only a medical advancement but also a guarantee of family happiness.

When embryo quality challenges make the fertility road full of bumps, professional forces often become the key to reversal. The IVF USA team founded by Dr. Nathan Zhang has been engaged in overseas assisted reproduction consulting services for over a decade, providing US egg freezing, US IVF, and third-party assisted reproduction services for those in need. IVF USA, deeply rooted in the overseas assisted reproduction field for nearly 20 years, based on the diversification and personalization of reproductive needs, has early laid out the Mexican market and become the agent in China for Power Fertility Center Mexico POWER Reproductive Center (POWER IVF). Currently, Dr. Nathan Zhang's business has expanded beyond the US to Mexico IVF and egg freezing, Japan and Thailand IVF and egg freezing, as well as Taiwan, Hong Kong, and other regions. You might as well leverage such support to let scientific screening and personalized care jointly escort you, helping you realize your fertility dreams.